This is a federal contract awarded by the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $412,217.17, is for HEART TRANSPLANT REJECTION TESTING services. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the ultimate completion date is February 28, 2022. The contract was awarded on September 1, 2016 and does not have a set-aside designation. Caredx provides specialized genetic and molecular testing solutions, including AlloMap and AlloSure testing kits, to assess organ rejection risks in transplant recipients. The company has been awarded multiple federal contracts with the VA, including two significant Indefinite Delivery Vehicle (IDV) contracts valued at $1,963,141.20 and $3,817,968 for genetic blood testing services and AlloSure kidney testing, respectively.